Hakm's abstract entitled "Focused ultrasound-triggered release of sorafenib from temperature sensitive liposomes for treating renal cell carcinoma" has been selected for oral presentation at the World Congress on Medical Physics and Biomedical Engineering in Toronto, Canada in June 2015.
